The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vancomycin 500 mg Powder for concentrate for solution for infusion

500 milligram(s) Pdr/Conc/Soln for Infus

Hikma Farmaceutica (Portugal) SAPA1217/009/001

Main Information

Trade NameVancomycin 500 mg Powder for concentrate for solution for infusion
Strength500 milligram(s)
Dosage FormPdr/Conc/Soln for Infus
Licence HolderHikma Farmaceutica (Portugal) SA
Licence NumberPA1217/009/001

Group Information

ATC CodeJ01XA Glycopeptide antibacterials
J01XA01 vancomycin


Licence Issued04/01/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back